$235.76
Price
$34.0B
Market Cap
22.6
P/E Ratio
17.8
Forward P/E
$10.44
EPS (TTM)
1.12%
Dividend Yield
$1.5B
Cash
$852M
Total Debt
144M
Shares Out
$180.27
$284.87
52-Week Range
Institutional Ownership of Resmed Inc
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| 387.7K | $76M | $246.54 | -4.37% |
Trading Activity for Resmed Inc
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2026-Q2 | |||||
| BUY | +68.5% | 387.7K | $76M | $206.76 | |
| 2026-Q1 | |||||
| SELL | -2.3% | 230.0K | $52M | $253.93 | |
| 2025-Q4 | |||||
| SELL | -0.0% | 235.4K | $57M | $252.11 | |
| 2025-Q3 | |||||
| BUY | NEW | 235.4K | $64M | $273.81 | |
| 2023-Q2 | |||||
| SELL | EXIT | — | — | $222.18 | |
| 2021-Q1 | |||||
| SELL | EXIT | — | — | $200.25 | |
| 2020-Q4 | |||||
| BUY | NEW | 356.3K | $76M | $209.21 | |
| 2020-Q3 | |||||
| BUY | NEW | 437 | $75000 | $180.68 | |
Insider Trading for Resmed Inc
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.